|
Volumn 316, Issue 5825, 2007, Pages 750-754
|
Reducing endogenous tau ameliorates amyloid β-induced deficits in an Alzheimer's disease mouse model
a a a a a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMYLOID BETA PROTEIN;
AMYLOID PRECURSOR PROTEIN;
BRAIN PROTEIN;
MICROTUBULE ASSOCIATED PROTEIN;
TAU PROTEIN;
DISEASE TREATMENT;
NERVOUS SYSTEM DISORDER;
PROTEIN;
RODENT;
ALZHEIMER DISEASE;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
BEHAVIOR DISORDER;
BRAIN DYSFUNCTION;
COGNITIVE DEFECT;
CONTROLLED STUDY;
DISEASE ASSOCIATION;
EXCITOTOXICITY;
LOCOMOTION;
MAZE TEST;
MOUSE;
NEUROPROTECTION;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
ALZHEIMER DISEASE;
AMYLOID BETA-PROTEIN;
AMYLOID BETA-PROTEIN PRECURSOR;
ANIMALS;
AXONS;
CONVULSANTS;
DISEASE MODELS, ANIMAL;
EXCITATORY AMINO ACID AGONISTS;
EXPLORATORY BEHAVIOR;
HIPPOCAMPUS;
HUMANS;
KAINIC ACID;
MAZE LEARNING;
MEMORY;
MICE;
MICE, INBRED C57BL;
MICE, TRANSGENIC;
MOTOR ACTIVITY;
PENTYLENETETRAZOLE;
PHOSPHORYLATION;
SEIZURES;
TAU PROTEINS;
MUS;
MUS MUSCULUS;
|
EID: 34248181511
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.1141736 Document Type: Article |
Times cited : (1601)
|
References (33)
|